We are live on
!
Find out more
EA
Emerald Advisers Portfolio holdings
AUM
$3.16B
1-Year Est. Return
109.58%
This Fund
S&P 500
This Quarter
Est. Return
-3.82%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$2.14B
AUM Growth
-$348M
(-14%)
Cap. Flow
-$183M
Cap. Flow
% of AUM
-8.54%
Top 10 Holdings %
Top 10 Hldgs %
19.87%
Holding
278
New
28
Increased
51
Reduced
132
Closed
33
Top Buys
| 1 |
AJRD
Aerojet Rocketdyne Holdings
AJRD
|
+$15.9M |
| 2 |
Pinnacle Financial Partners Inc
PNFP
|
+$15.8M |
| 3 |
Viavi Solutions
VIAV
|
+$15.1M |
| 4 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
+$12.5M |
| 5 |
PS
Pluralsight, Inc. Class A Common Stock
PS
|
+$9.83M |
Top Sells
| 1 |
CRAY
Cray, Inc.
CRAY
|
+$24.4M |
| 2 |
Innospec
IOSP
|
+$18.8M |
| 3 |
Teladoc Health
TDOC
|
+$15.8M |
| 4 |
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
|
+$11.6M |
| 5 |
SAVE
Spirit Airlines, Inc.
SAVE
|
+$10.1M |
Sector Composition
| 1 | Healthcare | 21.41% |
| 2 | Industrials | 17.43% |
| 3 | Consumer Discretionary | 17.37% |
| 4 | Technology | 13.96% |
| 5 | Financials | 8.72% |
Similar funds
AWE
FTUS
BFA
BP
CVA
DWP
GKWIM
BI
Emerald Advisers's Q3 2019 Portfolio in Review
As of Q3 2019, Emerald Advisers held 278 positions worth $2.14B, down 14% from $2.49B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Emerald Advisers withdrew a net $183M in Q3 2019, closing 33 positions and reducing 132 holdings. Its most notable exit was Cray, Inc., an estimated $24.4M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 22% a quarter earlier, followed by Industrials and Consumer Discretionary.
Against the trend, Emerald Advisers opened a new position in Aerojet Rocketdyne Holdings worth $16.5M.
- Emerald Advisers's largest Q3 2019 buy was Aerojet Rocketdyne Holdings: 327,583 shares worth $16.5M.
- Emerald Advisers added most to Pluralsight, Inc. Class A Common Stock in Q3 2019, an estimated $9.83M increase.
- Emerald Advisers's biggest Q3 2019 reduction was Teladoc Health, cutting an estimated $15.8M.
- Emerald Advisers fully exited Cray, Inc. in Q3 2019, selling an estimated $24.4M.
- Emerald Advisers's ten largest holdings make up 20% of its $2.14B portfolio in Q3 2019.
- Emerald Advisers opened 28 new positions and closed 33 in Q3 2019.
- Emerald Advisers's portfolio value fell 14% quarter-over-quarter to $2.14B.
Based on Emerald Advisers's 13F filing for Q3 2019, filed 31 Oct 2019.